C-Suite Leadership Strategy · The Step-Up
General Counsel and an IPO on the Horizon? Ready the Company — and Yourself
The listing will remake your company’s governance, its disclosure and its risk posture — and it will remake your job at the same time, from private-company guardian to listed-company officer.
An IPO is the moment a General Counsel’s role is rewritten from the inside out. You are being asked to make the company fit to be public — the board, the committees, the disclosures, the litigation clean-up — while simultaneously stepping up into a listed-company officer’s liability and standing. This engagement helps you close the readiness gap on both fronts, so the company arrives fit to list and you arrive fit to lead it there.
Does this sound like you?
If several of these land, this engagement is built for you.
- The board has decided to go public, and the readiness of the company’s governance, contracts and disclosures now sits, unmistakably, on your desk.
- You know the private-company legal function you have built beautifully is not the one a listed company needs, but the gap between the two has never been mapped.
- The bankers and the diligence teams are asking questions — related-party transactions, litigation, title, ESOP hygiene — that expose years of decisions taken at private-company speed.
- Your role is quietly changing from the person who protects the company to the person who has to make it disclosable, and no one has named that shift out loud.
- You will personally sign as an officer of a listed entity, with the liability that carries, and you are not yet sure the company is clean enough to let you sleep afterwards.
- You have run legal for a private group for years, and you suspect that being the GC of a public company is a different job you have never actually done.
Why the listing rewrites the legal function, not just the balance sheet
A general counsel facing IPO readiness is really facing two transformations wearing one deadline. The obvious one is the company’s: a private business that has made its decisions in private, at the pace and discretion its promoters preferred, has to become an entity whose governance, disclosures and controls can withstand a regulator, a set of underwriters and eventually a market of strangers. The less obvious one is yours. The legal function that served a private group — pragmatic, relationship-led, comfortable with informality because everyone in the room trusted everyone else — is not the function a listed company runs on, and the person who built the first is now expected to build and then operate the second.
This is why treating an IPO as a documentation exercise is the first and most expensive misread. The DRHP, the SEBI ICDR compliance, the material-contract disclosures and the litigation schedule are outputs; the input is a company whose way of taking and recording decisions has been rebuilt to be disclosable. Related-party transactions that were never a problem when the family owned everything become a governance question the moment outside shareholders exist. The GC who understands this leads the readiness; the one who does not is left assembling paper on top of a business that was never made fit underneath it.
The readiness gap that diligence is about to find
Every private company carries a backlog of decisions taken at private-company speed — a licence renewed late, a related-party lease never formalised, an ESOP grant with imperfect paperwork, a subsidiary whose title chain has a gap, a dispute settled on a handshake. None of it mattered while the company answered only to itself. All of it matters the moment a banker’s diligence team, a legal due-diligence firm and eventually a regulator start reading. The readiness gap is not the absence of a document; it is the accumulated distance between how the company actually ran and how a listed company is required to be able to prove it ran.
The GC’s task is to find that gap before the diligence teams do, because the difference between finding it yourself and having it found for you is the difference between a managed clean-up and a valuation event. A related-party transaction surfaced early is a governance item to remediate; the same item surfaced in the bankers’ red-flag report becomes a disclosure that spooks investors and shaves the price. Litigation, contingent liabilities, promoter-group dealings, regulatory notices — each has to be inventoried, assessed and either cured or cleanly disclosed on your timeline, not theirs.
- Related-party transactions — formalised, arm’s-length and disclosable, not informal promoter-group arrangements.
- Litigation and contingent liabilities — inventoried, assessed and either cured or cleanly disclosed.
- Corporate and title hygiene — subsidiary structure, licences, ESOP grants and share capital history cleaned before diligence, not during.
- Board and committee readiness — independent directors, audit and nomination committees constituted and actually functioning, not merely appointed.
The governance a public company runs on — and who has to build it
A listed company is a governance machine, and the GC is usually its architect and its operator both. Independent directors have to be found, inducted and made genuinely effective rather than decorative. Audit, nomination-and-remuneration and stakeholder-relationship committees have to be constituted, charged and run to a cadence that will survive scrutiny. The board’s way of taking decisions — its papers, its minutes, its conflict management, its related-party approvals — has to move from the informality of a private group to the disciplined, documented process a regulator and an outside shareholder expect. Much of this, in practice, is drafted, chased and stood up by the office of the general counsel and company secretary.
The trap is to build this governance as a facade for the listing and let it lapse the moment the shares are allotted. A company that constitutes committees to satisfy the DRHP and then reverts to promoter-led informality after listing is building a liability with a delay timer on it. The governance has to be real, because the obligations do not end at listing — they begin there. The GC who understands the difference between governance-for-the-prospectus and governance-that-runs-the-company builds the second, and in doing so builds the platform on which the company’s post-listing life, and their own credibility as its senior legal officer, will stand.
The personal step-up no one schedules for you
There is a version of this problem that has nothing to do with the company and everything to do with you, and it is the one most GCs under-prepare for. When the company lists, you become an officer of a public entity. Your signature carries a liability it never did before; your disclosures are read by a market and enforced by a regulator; your relationship with the board changes from adviser-to-the-promoters to guardian-of-a-listed-entity whose duty runs to all shareholders, not just the family that hired you. The company hires bankers, an IPO project team and a small army of advisers to manage its transition. Almost no one is retained to manage yours.
That step-up is a genuine change of role, not a change of workload, and pretending otherwise is how capable private-company GCs arrive under-prepared into a listed-company seat. The shift is from guardian to enabler-under-scrutiny: from the counsel who quietly kept the company safe to the officer who must publicly stand behind what the company says while still keeping it safe. Your standing with the new board, with the bankers, with the eventual investors is set in these months. Getting the company ready is necessary. Getting yourself ready — clear about the liability you are accepting, the authority you now need, and the version of the role you are stepping into — is what separates surviving the IPO from being enlarged by it.
The company hires bankers, lawyers and an IPO project team to manage its transformation. Almost no one is hired to manage yours — yet you are the officer whose signature, standing and liability all change the day the shares list.
Arriving fit to list — and fit to lead once listed
The aim of this work is a state in which both readinesses land together: a company that is genuinely fit to be public, and a general counsel who is genuinely fit to be its listed-company officer. Those are not the same project, and the reason so many GCs feel overwhelmed is that they are running both at once with only the first one named. Separate them, sequence them, and the IPO stops being a wave that breaks over you and becomes a transformation you are visibly steering — which is precisely how a board comes to see its GC as a leader of the enterprise rather than a technician who kept the paperwork tidy.
This engagement is built to hold both threads at once. Across two partner conversations, a diagnosis and a written roadmap, we map the company’s readiness gap and the personal step-up together — where the governance build actually stands, which diligence exposures to cure on your timeline, and what the move from private-company guardian to public-company officer demands of your authority, your board relationship and your own standing. The output is not legal advice on the prospectus; your bankers and firms supply that. It is a leadership roadmap for the person who has to make the company disclosable and become a public-company officer in the same eighteen months.
How it plays out
The group GC who had to make a family business disclosable
Consider the general counsel of a large, profitable, promoter-led consumer group — call her A — who had run its legal affairs superbly for eleven years. She knew where every body was buried because she had helped bury most of them at private-company speed: the related-party leases with promoter entities, the informal inter-company loans, the ESOP grants issued with more enthusiasm than paperwork, the two old disputes settled without ever being fully closed. Then the board decided to list, appointed bankers, and A discovered that the very informality that had made her effective for a decade was now the company’s largest readiness risk — and that all of it pointed back at her desk.
The diagnosis separated the two problems she had been experiencing as one. The first was the company’s: a genuine inventory of related-party transactions, contingent liabilities and corporate-hygiene gaps that had to be cured or cleanly disclosed before the bankers’ diligence team found them and priced the discovery in. The second was hers, and she had not named it: she was about to become the senior legal officer of a listed entity, personally accountable, with a board relationship that had to shift from promoter-confidante to guardian-of-all-shareholders. She had been treating a change of role as merely a spike in workload, and it was quietly frightening her without her understanding why.
The roadmap ran both threads deliberately and in sequence. On the company, she moved first on the exposures that would most damage the valuation if found late — formalising the related-party arrangements at arm’s length, closing the open disputes, cleaning the ESOP and title chains — and stood up the board committees to function, not to decorate the prospectus. On herself, she renegotiated her authority and reporting so she could actually deliver a listed company’s governance, and prepared deliberately for the officer’s liability she was accepting. The company listed without a diligence surprise. More quietly, A arrived on the other side not as the private-group lawyer who had survived an IPO, but as a public-company general counsel the new board plainly regarded as one of its leaders.
Illustrative composite — every engagement is calibrated to your specific situation.
What the two conversations cover
Session 1 · Diagnosis
- Map the company’s readiness gap — related-party transactions, litigation, corporate hygiene and committee readiness — and where diligence is most likely to find it first.
- Separate the company’s transformation from your own, and name the personal step-up from private-company guardian to listed-company officer that no one has scheduled for you.
- Assess your current authority, board relationship and standing against what a public-company GC actually requires to deliver.
Session 2 · The plan
- Sequence the readiness build so exposures that threaten the valuation are cured on your timeline, not surfaced in the bankers’ red-flag report.
- Design the governance that will run the company after listing — real committees and disciplined board process — not a facade for the prospectus.
- Set the personal roadmap for the officer’s role — the authority, liability and board standing you step into the day the shares list.
The mistakes to avoid
- Treating the IPO as a documentation exercise, assembling the prospectus on top of a business that was never made disclosable underneath it.
- Letting diligence teams find the related-party transactions and contingent liabilities first, turning a governance clean-up into a valuation event.
- Building committees and governance as a facade for the DRHP that lapses after listing, creating a liability with a delay timer on it.
- Managing the company’s transformation while ignoring your own, and arriving into a listed-company officer’s liability under-prepared for the role.
- Keeping the private-company board relationship of promoter-confidante when the listed company needs a guardian whose duty runs to all shareholders.
One offering · one outcome
- Two 60-minute one-to-one conversations with a senior Gladwin partner
- A complete diagnostic of where you stand in the market today
- A personalised repositioning roadmap you keep — your gap analysis and 90-day plan
C-Suite Leadership Strategy — Assessment and Roadmap
2 × 60-minute conversations · one booking
- Two 60-minute one-to-one conversations with a senior Gladwin partner
- A complete diagnostic of where you stand in the market today
- A personalised repositioning roadmap you keep — your gap analysis and 90-day plan
Loading available slots…
Frequently Asked Questions
It begins with the company, not the paper. The DRHP and the disclosures are outputs; the input is a business whose governance, contracts and decision-making have been rebuilt to be disclosable. If you start with the document, you spend the process assembling paper over exposures that were never cured. If you start with the company — the related-party transactions, the litigation, the corporate hygiene, the committees — the prospectus becomes a description of a company that is genuinely ready rather than a hopeful account of one that is not.
They run the transaction; you run the readiness. Bankers, book-running lead managers and the diligence firms will identify exposures, draft the prospectus and advise on SEBI compliance — but they do it to a document and a deadline, and they surface what they find as red flags that move the price. Curing those exposures on your timeline, standing up the governance that survives listing, and deciding what to disclose versus remediate is the GC’s leadership, not the advisers’. They tell you what is wrong. You are the one who has to have made it right.
It is a different job wearing the same title. Your signature carries an officer’s liability it never did before; your disclosures are read by a market and enforced by a regulator; and your duty shifts from serving the promoters who hired you to guarding an entity that now belongs to all its shareholders. The private-company virtues — informality, relationship-led pragmatism, decisions taken on trust — are exactly what a listed company cannot run on. Recognising that it is a role change, not a workload spike, is where the personal step-up begins.
Usually related-party transactions and the promoter-group dealings around them. In a private company these were unremarkable — the family owned everything, so an informal lease or inter-company loan raised no question. The moment outside shareholders exist, each becomes a governance and disclosure issue, and if the bankers’ diligence surfaces it before you have formalised it at arm’s length, it reads to investors as a governance red flag and shaves the price. Found early it is a remediation item. Found late it is a valuation event.
Both, and the personal preparation is the part almost everyone under-does. The company hires bankers, a project team and advisers to manage its transformation; virtually no one is retained to manage yours. Yet on listing day you become a public-company officer with new liability, a changed board relationship and a standing with investors that is set in these months. Capable private-company GCs arrive under-prepared into the listed seat precisely because they treated their own step-up as a busy patch rather than the role change it is.
It can go either way, and which way is partly your choice. Run the IPO as a technician assembling documents and you confirm the board’s picture of you as legal support. Run it as the person visibly steering the company’s governance transformation and your own step-up into a listed-company officer, and the board watches you lead through the most consequential event in the company’s life. The listing is one of the few moments when a GC can be re-seen as an enterprise leader — but only if you lead it rather than merely service it.
It is close to ideal. The exposures that damage a listing are the ones cured on your own timeline; eighteen months is enough to formalise related-party arrangements, close old disputes, clean the corporate hygiene and stand up committees that actually function before any diligence team reads them. It is also enough to prepare yourself deliberately for the officer’s role rather than discovering it on listing day. Start once the bankers are appointed and the red-flag report is written, and every move you make is a scramble rather than a plan.
Two 60-minute conversations with a partner, a written diagnostic that maps both the company’s readiness gap and your personal step-up from private-company guardian to listed-company officer, and a personalised roadmap document — which exposures to cure on your timeline, the governance to build so it survives listing, and how to step into the officer’s authority, liability and board standing. One price, incl. GST, or $250 internationally. It is leadership strategy, not legal advice on your prospectus, and there is nothing further to buy.